BP to update on cost-cutting progress as Elliot increases pressure, FT reports
Elliott wants BP CEO Murray Auchincloss to add another $5 billion of cost savings to the $4 billion-$5 billion in reductions by 2027 he announced in February from a 2023 baseline, the FT report said.
Reuters could not immediately verify the report. BP and Elliott did not immediately respond to a request for comment.
The hedge fund has "identified tens of thousands of BP support staff globally" as an example of the cost base, the report added.
BP has already cut $750 million of costs towards its target in 2024, and is looking to reach its cost savings target through job cuts, divestment and streamlining supply chains, the FT report said.
Reuters reported in April that the activist investor would like BP to cut its spending to around $12 billion a year, down from a current range of $13 billion-$15 billion, through to 2027, and deepen its cost cuts, especially on administrative expenses.
Elliott, which holds a stake of little more than 5% in BP, also wants the oil major to replace its strategy chief and create separate units for upstream and downstream activities to improve accountability.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 minutes ago
- Yahoo
Becton, Dickinson and Company Submits Application to the FDA for a New, At-Home HPV Test
Becton, Dickinson and Company (NYSE:BDX) is one of the . On July 31, Becton, Dickinson and Company (NYSE:BDX) announced that it submitted an application to the U.S. FDA for a new, at-home HPV test. The new HPV test focuses on patients to self-collect a sample at their home using a swab, the size of a Q-tip, simplifying lab processing. According to BD, this method also reports more high-risk strains of HPV compared to other tests on the market today. A person wearing a state-of-the-art medical device for nerve conduction tests. 'We envision a world where women are empowered with access and a choice for their HPV screening, whether it be in a routine visit at the doctor's office or the comfort and privacy of their own home via a self-collected sample. Cervical cancer and the loss of more than 4,000 women per year to this devastating disease is preventable, and we believe at-home testing is an important leap forward to our goal of eliminating this type of cancer,' said Nikos Pavlidis, president of BD Diagnostic Solutions. BD's new HPV test will include a state-of-the-art self-collection swab technology that also offers convenient mailing from home to the lab, supporting broader participation in cervical cancer screening programs. The self-collected swab requires no manual sample preparation by clinical laboratory technologists. This process will allow them to focus on higher-value work. Becton, Dickinson and Company (NYSE:BDX) is a global medical technology company that focuses on the development, manufacturing, and sale of various medical supplies, devices, diagnostic products, and laboratory equipment. While we acknowledge the potential of BDX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Axon Enterprise (AXON) Vs Palantir Technologies (PLTR): Which is the Better Investment?
Strong Q2 results have led to a further uproar in Axon Enterprise AXON and Palantir Technologies PLTR shares this week, remaining two of the hottest momentum stocks. Axon's stock has now spiked over +40% year to date, with Palantir shares surging more than +130%. More astonishing, AXON is up over +640% in the last three years with PLTR skyrocketing more than 1,700%. Considering their millionaire-maker-like gains, investors are surely wondering which of these hot stocks is the better investment at the moment. Image Source: Zacks Investment Research Axon Thrives on Increased Public Safety Spending Thanks to increased global defense and public safety spending, Axon easily surpassed its Q2 expectations while posting stellar top and bottom line growth. The innovative manufacturer of weapons for the U.S. and international governments posted Q2 sales of $668.54 million, which soared nearly 33% year over year and comfortably topped estimates of $642.98 billion by 4%. Furthermore, this marked the 14th consecutive quarter of revenue growth above 25%, with CEO Rick Smith stating Axon is seeing broad demand across the company's portfolio, including for its AI services, drones, cameras, and virtual reality solutions. More impressive, Axon's Q2 earnings came in at $2.12 per share, crushing expectations of $1.54 by 37% and soaring 76% from $1.20 in the prior period. Axon has now exceeded the Zacks EPS Consensus for a remarkable 33 consecutive quarters, with a very impressive average earnings surprise of 25.87% in its last four quarterly reports. Image Source: Zacks Investment Research Palantir's First Billion-Dollar Quarter Also thriving from increased defense spending, including the securement of a $10 billion contract with the U.S. Army, Palantir achieved its first-ever billion-dollar quarter, topping estimates of $938.33 million. This was a 48% spike from Q2 sales of $678.13 million a year ago, as the software provider saw strong demand for its artificial intelligence platform (AIP) outside of the intelligence communities. Pinpointing increased commercial demand for AIP, Palantir CEO Alex Karp stated that companies are using Palantir's tools not just to optimize operations, but to reshape entire business models. Palantir is also taking advantage of its expansive sales growth, with Q2 EPS of $0.16 rising from $0.09 a share in the comparative quarter and edging expectations of $0.14. Notably, Palantir has now reached of exceeded the Zacks EPS Consensus for 11 consecutive quarters with an average earnings surprise of 13.17% over the last four quarters. Image Source: Zacks Investment Research Axon & Palantir Raise Their Full-Year Guidance Adding fuel to investor sentiment is that Axon and Palantir have raised their full-year revenue guidance. Optimistically, Axon now forecasts fiscal 2025 revenue at $2.65-$2.73 billion, up from $2.6-$2.7 billion. It's also noteworthy that Axon expects full-year adjusted EBITDA of $665-$685 million, raised from $650-$675 million. Pivoting to Palantir, the company raised its FY25 revenue forecast to $4.142 billion-$4.15 billion, up from previous guidance of $3.89 billion-$3.9 billion. The bump is specifically attributed to full-year commercial revenue guidance increasing to over $1 billion, reflecting at least 85% growth. Additionally, Palantir raised its adjusted income from operations guidance to between $1.912 billion-1.92 billion and increased its adjusted free cash flow guidance to $1.8 billion-$2 billion. Monitoring Axon & Palantir's Valuation While Axon is well ahead in terms of moving further past the probability line than Palantir, the price-to-sales ratio may still be a better indicator of judging the value these hot stocks offer to investors at their current levels, rather than price-to-earnings. That said, Axon is also growing into its lofty valuation more swiftly regarding the P/S ratio after a rebranding to reflect its broader mission in public safety technology. To that point, Axon trades at 25X forward sales, which is far more reasonable than Palantir's 104X. Image Source: Zacks Investment Research Conclusion & Final Thoughts Although Palantir's ability to benefit from the AI boom makes it the better momentum stock at the moment, Axon appears to be the overall better investment when considering its more justifiable valuation. Axon's profitability also makes it a more sound investment, and earnings estimate revisions (EPS) have remained higher, correlating with AXON sporting a Zacks Rank #1 (Strong Buy). On the other hand, Palantir stock lands a Zacks Rank #3 (Hold), and investors may certainly be looking for better entry points given PLTR doesn't offer much fundamental value after such a monstrous year-to-date rally. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Axon Enterprise, Inc (AXON) : Free Stock Analysis Report Palantir Technologies Inc. (PLTR) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Sunningdale Tech to acquire Sanwa Group to strengthen its position as an Asian powerhouse in precision plastics solutions
The acquisition will solidify Sunningdale Tech's position as one of the largest precision plastics engineering companies with a total combined revenue of approximately S$850m This highly synergistic acquisition will allow the Group to further diversify its customer base, broaden its product portfolio, enter the industrial segment, enhance its engineering capabilities and penetrate new markets Post-acquisition, the expansion of the Group's global footprint to 23 locations in nine countries enhances its position as a global powerhouse with the ability to support multinational customers in various geographic regions The acquisition is in line with the Group's strategy to accelerate the transformation of its automotive segment to focus more on the manufacturing of complex functional parts and critical EV components SINGAPORE, Aug. 7, 2025 /PRNewswire/ -- Sunningdale Tech Ltd ("Sunningdale Tech" or "the Group"), a leading global manufacturer of precision-engineered plastic components, has announced it has entered into a sale and purchase agreement to acquire Sanwa Plastic Industry Pte Ltd ("Sanwa Group"). Upon completion of this all-cash acquisition, the merger will effectively solidify Sunningdale Tech's position as one of the largest precision plastics engineering companies in the region with a total combined revenue of approximately S$850 million based on figures from the financial year ended 31 December 2024. Today, Sanwa Group is renowned as a trusted precision plastic component manufacturer with deep penetration in fast-growing automotive segments which focus on green mobility and future vehicle design. Sanwa Group also has exposure to stable end segments in the industrial, energy, consumer and biomedical industries. Sanwa Group operates across seven manufacturing sites in China, Indonesia, India and Singapore. The company has established an excellent reputation as an integrated manufacturer with proven reliability and an operating track record of more than 45 years, led by its visionary Chief Executive Officer, Dr Ricky Souw, who will stay on as an advisor to Sunningdale Tech following the completion of the merger. The acquisition is highly synergistic as customer or product overlap is minimal between the two companies. In addition, the acquisition will allow Sunningdale Tech to further diversify its customer base, enhance its engineering capabilities, enter the industrial segment and penetrate new markets. The acquisition is also in line with the Group's strategy to accelerate the transformation of its automotive business to focus more on the manufacturing of functional parts and critical EV components. Post-completion, Sunningdale Tech will expand its geographic footprint to 23 locations in nine countries as it continues to support multinational customers in various regions amid shifts in global supply chains. Commenting on the acquisition, Group CEO & Executive Director Mr Khoo Boo Hor said, "We are delighted to partner with Sanwa Group as our vision to become a world-leading precision plastic solutions provider continues to unfold. This strategic and highly synergistic acquisition will put us in a formidable position to take advantage of growth opportunities worldwide and better serve our customers, leveraging on our combined technical knowhow and engineering capabilities." Echoing similar sentiments, Sanwa Group's CEO Dr Ricky Souw said, "For more than four decades, we have built up Sanwa Group to become one of Asia's leading precision plastics engineering companies and we are remarkably proud for all that we have achieved. Partnering with Sunningdale Tech is a natural progression and an ideal fit as we share a similar set of values and a vision of becoming a global powerhouse. We look forward to ringing in a new chapter for Sanwa Group and soaring to new heights in partnership with Sunningdale Tech." Oversea-Chinese Banking Corporation Limited (OCBC) is acting as the sole financial advisor to Sanwa Group. About Sunningdale Tech Ltd. Sunningdale Tech Ltd is a leading global manufacturer of precision-engineered plastic components. The Group provides vertically integrated solutions with capabilities including product and mould design, mould fabrication, injection moulding, complementary finishing, and precision assembly of complete products. The Group boasts over 1,150 injection moulding machines with a tooling capacity of 2,000 moulds per year across a global footprint which spans 17 manufacturing locations in nine countries. With over four million square feet of manufacturing facilities, the Group operates in Singapore, China, India, Indonesia, Latvia, Malaysia, Mexico, Thailand, and the USA. The Group produces precision engineered plastic components for multinational customers in the Automotive, Consumer/IT and Healthcare industries. More recently, the Group has been focused on accelerating the growth of its Healthcare segment, the Group's fastest growing vertical in recent years. For more information, please visit About Sanwa Plastic Industry Pte Ltd ("Sanwa Group") Established since 1977, Sanwa Group specialises in precision plastic injection moulding, insert moulding, and component sub-assembly. With a passion and focus to constantly evolve and innovate to improve its competitive edge and service quality, Sanwa Group has grown into an industry leader, offering fully integrated manufacturing solutions for multinational customers in the automotive, energy, industrial, consumer and biomedical industries. Headquartered in Singapore, Sanwa Group also has offices and state-of-the-art manufacturing facilities across China, India and Indonesia. For more information, please visit For media and investor queries, please contact: James Bywater, CFADirector, Corporate Strategy, Marketing & PRSunningdale Tech LtdEmail: View original content to download multimedia: SOURCE Sunningdale Tech Ltd
